8-chloroadenosine,
8-Chloroadenosine,
34408-14-5,
UNII-PA05MFH3I7,
Adenosine, 8-chloro-,
PA05MFH3I7,
8-Chloro-adenosine,
(2R,3R,4S,5R)-2-(6-amino-8-chloro-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol,
8-Cl-Ado,
Adenosine,8-chloro,
AK481203,
AC1L3VFP,
SCHEMBL987728,
CTK1C6147,
(2R,3R,4S,5R)-2-(6-amino-8-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
MHDPPLULTMGBSI-UUOKFMHZSA-N,
ZINC3963660,
MFCD01076457,
AKOS024284395,
SB17113,
AN-36385,
ST075649,
408C145,
(4S,2R,3R,5R)-2-(6-amino-8-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol,
D03OVA,
Nucleoside analogs (cancer),
2-Chloroadenosine Hemidydrate,
C10-H12-Cl-N5-O4,
CID147569,
Nucleoside analogs (cancer), MD Anderson Cancer Center,
81012-94-4,
N/A,